hae_ʻaoʻao

huahana

Mea hana pauka Nefiracetam CAS No.: 77191-36-7 99% maʻemaʻe min. no nā mea hoʻohui

Wehewehe Pōkole:

No ka papa lāʻau lapaʻau hoʻonui naʻauao palena ʻole ʻo Nefiracetam, nona nā ʻano kemika like ʻole a hoʻonui i ka hiki ke ʻike a pale i ka hōʻino ʻia o ke aʻo ʻana a me ka hoʻomanaʻo ma o ko lākou hopena ma ka cerebral cortex.


Nā kikoʻī huahana

Nā Lepili Huahana

Wikiō Huahana

Nā Palena Huahana

Inoa huahana

ʻO Nefiracetam

Inoa ʻē aʻe

n-(2,6-dimethylphenyl)-2-oxo-1-pyrrolidineacetamide;NEFIRACETAM;

2-oxo-1-pyrrolidinylaceticacid,2,6-dimethylanilide;

dm9384;

n-(2,6-dimethylphenyl)-2-oxo-1-pyrrolidineacetamid;DM-9384,(2-(2-Oxopyrrolidin-1-yl)-N-(2,6-dimethylphenyl)-acetamide);

DMMPA

Helu CAS.

77191-36-7

ʻO ke ʻano molekole

C14H18N2O2

Kaumaha molekole

246.3

Maʻemaʻe

99.0%

helehelena

Pauka keʻokeʻo

Hoʻopili ʻana

25 kg/barela

Noi

nootropic

Hoʻolauna huahana

No ka ʻohana piracetam ʻo Nefiracetam, kahi papa o nā lāʻau lapaʻau i ʻike ʻia no ko lākou mau waiwai hoʻonui ʻike. Ua hoʻohui mua ʻia ʻo Nefiracetam i ka hoʻomaka ʻana o nā makahiki 1980 a ua huki koke ʻia ka manaʻo ma muli o kāna ʻano hana kūikawā a me nā noi therapeutic hiki. Manaʻo ʻia kēia hui racemic e hoʻopilikia i nā neurotransmitters a me nā mea loaʻa i loko o ka lolo, e hoʻolaha ana i nā hiki ke hoʻomaikaʻi ʻia. Hoʻopilikia nui ʻo Nefiracetam i nā pae lolo o ka acetylcholine, kahi neurotransmitter koʻikoʻi kuleana no ka hoʻomanaʻo, ke aʻo ʻana, a me ka hana ʻike. Ma ka hoʻololi ʻana i nā mea loaʻa acetylcholine, hoʻolaha ʻo nefiracetam i ka hoʻonui ʻana i ka kamaʻilio ma waena o nā neurons, no laila e hoʻonui ai i ka plasticity synaptic a hoʻomaikaʻi i ka paʻa ʻana o ka hoʻomanaʻo. Eia kekahi, launa pū ʻo nefiracetam me nā mea loaʻa gamma-aminobutyric acid (GABA) e kōkua i ke kaulike ʻana o ka neurotransmitter milieu. Ma ka hoʻopilikia maikaʻi ʻana i nā neurotransmitters excitatory a me inhibitory, kōkua ʻo nefiracetam i ka mālama ʻana i ka hana maikaʻi loa o ka lolo, no laila e hoʻomaikaʻi ana i ka nānā ʻana, ka nānā ʻana, a me ka hana ʻike holoʻokoʻa.

Hiʻona

(1) Maʻemaʻe kiʻekiʻe: Hiki iā Nefiracetam ke loaʻa nā huahana maʻemaʻe kiʻekiʻe ma o nā kaʻina hana hoʻomaʻemaʻe. ʻO ke ʻano o ka maʻemaʻe kiʻekiʻe ʻoi aku ka maikaʻi o ka bioavailability a me nā hopena maikaʻi ʻole.

(2) Palekana: Palekana kiʻekiʻe, kakaikahi nā hopena maikaʻi ʻole.

(3) Paʻa: He kūpaʻa maikaʻi ko Nefiracetam a hiki ke mālama i kāna hana a me kona hopena ma lalo o nā ʻano like ʻole a me nā kūlana mālama.

Nā noi

ʻO Nefiracetam kahi derivative hydrophobic o piracetam, kahi i manaʻo nui ʻia he mea kuleana no ka ʻike ʻana o nā kahawai calcium i loko o ke kino a me ka hoʻoili pololei ʻole ʻana o nā mea hōʻailona hoʻonāukiuki ma ke ʻano he agonist hapa o nā kahawai ion calcium. Kahi hoʻopaʻa Glycine o ka receptor NDMA. Ma o kona hopena ma ka cortex cerebral, hiki i ka nefiracetam ke hoʻonui i nā hiki cognitive a pale i ke aʻo ʻana a me ka hoʻomanaʻo ʻana. ʻAʻohe ona waiwai agonist receptor muscarinic a i ʻole antagonist, ʻaʻole hoʻi e kāohi i ka hana acetylcholinease. No laila, ua hoʻokō ʻia kāna mau hopena anti-amnestic a me ka hoʻonui ʻana i ka hoʻomanaʻo ma ka hoʻomaikaʻi ʻana i ka hoʻokuʻu ʻana o ka acetylcholine i loko o ka cortex cerebral.


  • Ma mua:
  • Aʻe:

  • E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou